2021 ICD-10-CM Code C80.2
Malignant neoplasm associated with transplanted organ
Valid for Submission
C80.2 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm associated with transplanted organ. The code C80.2 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C80.2 might also be used to specify conditions or terms like donor derived melanoma, metastatic malignant melanoma or post-transplant neoplasia.
The code C80.2 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic associated with transplanted organ .
ICD-10: | C80.2 |
Short Description: | Malignant neoplasm associated with transplanted organ |
Long Description: | Malignant neoplasm associated with transplanted organ |
Code Classification
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C80.2:
Code First
Code FirstCertain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- complication of transplanted organ T86
Use Additional Code
Use Additional CodeThe “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
- code to identify the specific malignancy
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C80.2 are found in the index:
- - Complication (s) (from) (of)
- - transplant - T86.90
- - malignant neoplasm - C80.2
- - transplant - T86.90
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Donor derived melanoma
- Metastatic malignant melanoma
- Post-transplant neoplasia
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code C80.2 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
- 826 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC - Relative Weight: 5.0368
- 827 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC - Relative Weight: 2.4976
- 828 - MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC - Relative Weight: 1.6777
Convert C80.2 to ICD-9 Code
- 199.2 - Malig neopl-transp organ
Table of Neoplasms
The code C80.2 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
---|---|---|---|---|---|---|
»Neoplasm, neoplastic »associated with transplanted organ | C80.2 |
Information for Patients
Cancer
Also called: Carcinoma, Malignancy, Neoplasms, Tumor
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.
NIH: National Cancer Institute
- Cancer (Medical Encyclopedia)
- Cancer and lymph nodes (Medical Encyclopedia)
- Cancer treatment -- early menopause (Medical Encyclopedia)
- Cancer treatment: preventing infection (Medical Encyclopedia)
- Cancer treatments (Medical Encyclopedia)
- How to research cancer (Medical Encyclopedia)
- How to tell your child that you have cancer (Medical Encyclopedia)
- Hyperthermia for treating cancer (Medical Encyclopedia)
- Laser therapy for cancer (Medical Encyclopedia)
- Photodynamic therapy for cancer (Medical Encyclopedia)
- Targeted therapies for cancer (Medical Encyclopedia)
- Understanding your cancer prognosis (Medical Encyclopedia)
- Your cancer care team (Medical Encyclopedia)
- Your cancer diagnosis: Do you need a second opinion? (Medical Encyclopedia)
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)